One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

NCT00695955 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

669

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Azilsartan medoxomil with or without add-on chlorthalidone
DRUG: Azilsartan medoxomil with or without add-on hydrochlorothiazide

Sponsor

Takeda